β-blockers Reverse Agonist-Induced β<sub>2</sub>-AR Downregulation Regardless of Their Signaling Profile

β-blockers Reverse Agonist-Induced β<sub>2</sub>-AR Downregulation Regardless of Their Signaling Profile

Altered &#946;-adrenergic receptor (&#946;-AR) density has been reported in cells, animals, and humans receiving &#946;-blocker treatment. In some cases, &#946;-AR density is upregulated, but in others, it is unaffected or even reduced. Collectively, these results would imply that ch...

Full description

Bibliographic Details
Main Authors: Sonia Maccari, Vanessa Vezzi, Federica Barbagallo, Tonino Stati, Barbara Ascione, Maria Cristina Grò, Liviana Catalano, Giuseppe Marano, Paola Matarrese, Caterina Ambrosio, Paola Molinari
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:International Journal of Molecular Sciences
Subjects:
pharmacology
cell surface receptor density
β-blockers
cultured cells
lymphocytes
Online Access:https://www.mdpi.com/1422-0067/21/2/512

Internet

https://www.mdpi.com/1422-0067/21/2/512

Similar Items